Literature DB >> 7825467

A review: the active peptide of lactoferrin.

M Tomita1, M Takase, W Bellamy, S Shimamura.   

Abstract

A potent antimicrobial peptide, 'lactoferricin', was found to be generated upon gastric pepsin cleavage of lactoferrin. The active peptide consists mainly of a loop of 18 amino acid residues, derived from the N-terminal region of the lactoferrin molecule. Like various other antimicrobial peptides that display membrane-disruptive properties, it contains a high proportion of basic amino acid residues. A physiologically diverse range of micro-organisms was tested and found to be susceptible to inhibition by this natural peptide including Gram-negative and Gram-positive bacteria, yeasts and filamentous fungi. Its antimicrobial effect against sensitive micro-organisms was lethal. Electron microscopy studies revealed that it induces a profound change in cell ultrastructural features and causes substantial cell damage in bacteria and fungi. These findings suggest the possibility that active peptides of lactoferrin may have a role in the host defense against microbial disease. If produced in substantial quantities in vivo such peptides could have important physiological significance, especially in nursing infants.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7825467     DOI: 10.1111/j.1442-200x.1994.tb03250.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  27 in total

1.  Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.

Authors:  L A Håversen; I Engberg; L Baltzer; G Dolphin; L A Hanson; I Mattsby-Baltzer
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Giardicidal activity of lactoferrin and N-terminal peptides.

Authors:  J M Turchany; S B Aley; F D Gillin
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

3.  Membrane potential is vital for rapid permeabilization of plasma membranes and lipid bilayers by the antimicrobial peptide lactoferricin B.

Authors:  Farzana Hossain; Md Mizanur Rahman Moghal; Md Zahidul Islam; Md Moniruzzaman; Masahito Yamazaki
Journal:  J Biol Chem       Date:  2019-05-22       Impact factor: 5.157

4.  The structure and evolution of the murine inhibitor of carbonic anhydrase: a member of the transferrin superfamily.

Authors:  Brian E Eckenroth; Anne B Mason; Meghan E McDevitt; Lisa A Lambert; Stephen J Everse
Journal:  Protein Sci       Date:  2010-09       Impact factor: 6.725

5.  Effect of membrane potential on entry of lactoferricin B-derived 6-residue antimicrobial peptide into single Escherichia coli cells and lipid vesicles.

Authors:  Farzana Hossain; Hideo Dohra; Masahito Yamazaki
Journal:  J Bacteriol       Date:  2021-02-08       Impact factor: 3.490

6.  Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.

Authors:  E Elass-Rochard; D Legrand; V Salmon; A Roseanu; M Trif; P S Tobias; J Mazurier; G Spik
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs.

Authors:  Leonard T Nguyen; Johnny K Chau; Nicole A Perry; Leonie de Boer; Sebastian A J Zaat; Hans J Vogel
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

8.  Antibiotic properties of bovine lactoferrin on Helicobacter pylori.

Authors:  E J Dial; L R Hall; H Serna; J J Romero; J G Fox; L M Lichtenberger
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

Review 9.  Archetypal tryptophan-rich antimicrobial peptides: properties and applications.

Authors:  Nadin Shagaghi; Enzo A Palombo; Andrew H A Clayton; Mrinal Bhave
Journal:  World J Microbiol Biotechnol       Date:  2016-01-09       Impact factor: 3.312

Review 10.  Peptide design for antimicrobial and immunomodulatory applications.

Authors:  Evan F Haney; Robert E W Hancock
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.